SCHEDULE: Goldman Sachs Reports Stake in HCM IV Acquisition Corp
Beneficial Ownership Filing (Schedule 13G)
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 5.2% of HCM IV Acquisition Corp's Class A Ordinary Shares as of June 30, 2026.
Summary
- The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC are filing a Schedule 13G, indicating they beneficially own 1,485,647 shares of HCM IV Acquisition Corp's Class A Ordinary Shares.
- This ownership represents 5.2% of the class of securities.
- The filing is made as of June 30, 2026, with the event requiring the filing occurring on this date.
- Goldman Sachs & Co. LLC is identified as a broker-dealer, options trader, and investment adviser.
- The filing asserts that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting beneficial ownership changes without significant operational or financial disclosures.
Positives
- Goldman Sachs & Co. LLC's status as a registered broker-dealer and investment adviser suggests adherence to regulatory frameworks.
- The explicit statement that shares are held in the ordinary course of business and not for control purposes indicates standard investment activity.
Negatives
- The filing does not provide any operational or financial performance data for HCM IV Acquisition Corp, limiting insight into the company's health.
Risks
- As a Schedule 13G filing, it primarily reports ownership and does not detail specific risks associated with HCM IV Acquisition Corp's business operations or future prospects.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding HCM IV Acquisition Corp's future performance.
Management Comments
- The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that this filing is typical for investment firms like Goldman Sachs, which often hold significant stakes in various companies, including special purpose acquisition companies (SPACs) like HCM IV Acquisition Corp, as part of their investment and trading activities.
Comparison to Industry Standards
- This filing aligns with standard Schedule 13G reporting requirements for institutional investors exceeding a 5% beneficial ownership threshold in a publicly traded company.
- The ownership percentage of 5.2% is a common threshold that triggers such filings for entities like The Goldman Sachs Group, Inc. and its subsidiaries.
Stakeholder Impact
- Shareholders of HCM IV Acquisition Corp are informed of a significant institutional investor's stake, which could influence market perception and trading activity.
Next Steps
- No specific next steps are outlined in this filing beyond the reporting of current beneficial ownership.
Key Dates
| Date | Description |
|---|---|
| 07/16/2025 | Previous Power of Attorney granted by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC. |
| 06/30/2026 | Date of event which requires filing of this statement (acquisition of shares). |
| 07/02/2026 | Effective date for Power of Attorney granted by Goldman Sachs & Co. LLC. |
| 07/08/2026 | Effective date for Power of Attorney granted by The Goldman Sachs Group, Inc. |
| 07/29/2026 | Date of filing of the Schedule 13G and Joint Filing Agreement. |
| 07/08/2027 | Expiration date for Power of Attorney granted by The Goldman Sachs Group, Inc. |
| 07/02/2027 | Expiration date for Power of Attorney granted by Goldman Sachs & Co. LLC. |
Keywords
Schedule 13G, Beneficial Ownership, HCM IV Acquisition Corp, Class A Ordinary Shares, Goldman Sachs, Acquisition Corp, Investment Holding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.